New biologic tools in psychiatry

Adriana Elena Foster

Research output: Contribution to journalReview article

Abstract

A variety of tests are used in the research setting, some have a role in clinical practice and others may be used in the clinic at some future time (Table 3). Genetic testing for CYP-450 enzymes with the AmpliChip is starting to penetrate clinical research, and guidelines will be elaborated soon to help clinicians in its use. The other tools are in earlier stages of clinical application. Time will tell whether these tools can prove their effectiveness and diagnostic specificity. In addition, they will have to become cost-effective to gain payer support. If these tools prove to advance our ability to diagnose and treat mental illness, our role will extend to educating the patients, the public, and the service planners about them.

Original languageEnglish (US)
Pages (from-to)44-48
Number of pages5
JournalPsychiatric Times
Volume23
Issue number8
StatePublished - Dec 1 2006

Fingerprint

Psychiatry
Aptitude
Genetic Testing
Research
Guidelines
Costs and Cost Analysis
Enzymes

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Psychiatry and Mental health

Cite this

Foster, A. E. (2006). New biologic tools in psychiatry. Psychiatric Times, 23(8), 44-48.

New biologic tools in psychiatry. / Foster, Adriana Elena.

In: Psychiatric Times, Vol. 23, No. 8, 01.12.2006, p. 44-48.

Research output: Contribution to journalReview article

Foster, AE 2006, 'New biologic tools in psychiatry', Psychiatric Times, vol. 23, no. 8, pp. 44-48.
Foster AE. New biologic tools in psychiatry. Psychiatric Times. 2006 Dec 1;23(8):44-48.
Foster, Adriana Elena. / New biologic tools in psychiatry. In: Psychiatric Times. 2006 ; Vol. 23, No. 8. pp. 44-48.
@article{f66fa7e9710d4e779526b2d3e3b72753,
title = "New biologic tools in psychiatry",
abstract = "A variety of tests are used in the research setting, some have a role in clinical practice and others may be used in the clinic at some future time (Table 3). Genetic testing for CYP-450 enzymes with the AmpliChip is starting to penetrate clinical research, and guidelines will be elaborated soon to help clinicians in its use. The other tools are in earlier stages of clinical application. Time will tell whether these tools can prove their effectiveness and diagnostic specificity. In addition, they will have to become cost-effective to gain payer support. If these tools prove to advance our ability to diagnose and treat mental illness, our role will extend to educating the patients, the public, and the service planners about them.",
author = "Foster, {Adriana Elena}",
year = "2006",
month = "12",
day = "1",
language = "English (US)",
volume = "23",
pages = "44--48",
journal = "Psychiatric Times",
issn = "0893-2905",
publisher = "Psychiatric Times",
number = "8",

}

TY - JOUR

T1 - New biologic tools in psychiatry

AU - Foster, Adriana Elena

PY - 2006/12/1

Y1 - 2006/12/1

N2 - A variety of tests are used in the research setting, some have a role in clinical practice and others may be used in the clinic at some future time (Table 3). Genetic testing for CYP-450 enzymes with the AmpliChip is starting to penetrate clinical research, and guidelines will be elaborated soon to help clinicians in its use. The other tools are in earlier stages of clinical application. Time will tell whether these tools can prove their effectiveness and diagnostic specificity. In addition, they will have to become cost-effective to gain payer support. If these tools prove to advance our ability to diagnose and treat mental illness, our role will extend to educating the patients, the public, and the service planners about them.

AB - A variety of tests are used in the research setting, some have a role in clinical practice and others may be used in the clinic at some future time (Table 3). Genetic testing for CYP-450 enzymes with the AmpliChip is starting to penetrate clinical research, and guidelines will be elaborated soon to help clinicians in its use. The other tools are in earlier stages of clinical application. Time will tell whether these tools can prove their effectiveness and diagnostic specificity. In addition, they will have to become cost-effective to gain payer support. If these tools prove to advance our ability to diagnose and treat mental illness, our role will extend to educating the patients, the public, and the service planners about them.

UR - http://www.scopus.com/inward/record.url?scp=33846490677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846490677&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:33846490677

VL - 23

SP - 44

EP - 48

JO - Psychiatric Times

JF - Psychiatric Times

SN - 0893-2905

IS - 8

ER -